Functional exhaustion of antiviral lymphocytes in COVID-19 patients

Cited by (1,000)

Items 701–800 of 1,000

1. A High Neutrophil-Lymphocyte Ratio Is Associated With Increased Morbidity and Mortality in Patients With Coronavirus Disease 2019
   Alexander Harrison King, Omar Mehkri, Prabalini Rajendram, Xiaofeng Wang, Vidula Vachharajani, Abhijit Duggal · 2021 · Critical Care Explorations
2. Immune cell profiling and antibody responses in patients with COVID-19
   Mitra Sadat Rezaei, Shima Mahmoudi, Esmaeil Mortaz, Majid Marjani · 2021 · BMC Infectious Diseases
3. COVID-19 in Patients with Hematologic Malignancies: Clinical Manifestations, Persistence, and Immune Response
   Ivan Gur, Amir Giladi, Yonathan Nachum Isenberg, Ami Neuberger, Anat Stern · 2022 · Acta Haematologica
4. Herpes zoster in the era of COVID 19: A prospective observational study to probe the association of herpes zoster with COVID 19 infection and vaccination
   Nawaf Al-Mutairi, Abdulrahman N. Almutairi, Moneerah Almazyad, Sabika Alwazzan · 2022 · Dermatologic Therapy
5. Immune responses to SARS-CoV-2 in dialysis and kidney transplantation
   Chiara Cantarelli, Andrea Angeletti, Laura Perin, Luis Sanchez Russo, Gianmarco Sabiu, Manuel Alfredo Podestà, Paolo Cravedi · 2022 · Clinical Kidney Journal
6. A peptide derived from HSP60 reduces proinflammatory cytokines and soluble mediators: a therapeutic approach to inflammation
   María del Carmen Domínguez-Horta, Anabel Serrano Díaz, Mabel Hernández-Cedeño, Gillian Martínez‐Donato, Gerardo E Guillén · 2023 · Frontiers in Immunology
7. Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement
   Matt Coban, Juliet Morrison, S. Maharjan, David Hyram Hernandez Medina, Wan-Lu Li, Y. S. Zhang, W. Freeman, Evette S. Radisky, K. L. Le Roch, Carla M. Weisend et al. · 2020 · Biomolecules
8. Angiotensin‐converting enzyme 2: A protective factor in regulating disease virulence of SARS‐COV‐2
   Vignesh Mariappan, Rao S.R., Agieshkumar Balakrishna Pillai · 2020 · IUBMB Life
9. An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection
   Devaux, Christian A., Camoin-Jau, Laurence · 2022 · Frontiers in Microbiology
10. CAR-NK cell therapy: a potential antiviral platform
    Ming-Hao Lin, Lijuan Hu, Jeffrey S. Miller, Xiao‐Jun Huang, Xiang-Yu Zhao · 2025 · 中国科学通报：英文版
11. COVID-19 as a Possible Cause of Functional Exhaustion of CD4 and CD8 T-cells and Persistent Cause of Methicillin-Sensitive Staphylococcus aureus Bacteremia
    Ivana Choudhury, Haowei Han, Kaushik Manthani, Sandeep A. Gandhi, Rameshchandra Dabhi · 2020 · Cureus
12. Does Angiotensin II Peak in Response to SARS-CoV-2?
    Léder Leal Xavier, Paula Fernanda Ribas Neves, Lisiê Valéria Paz, Laura Tartari Neves, Pamela Brambilla Bagatini, Luís Fernando Saraiva Macedo Timmers, Alberto A. Rasia‐Filho, Régis Gemerasca Mestriner, Andréa Wieck · 2021 · Frontiers in Immunology
13. Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19
    Johannes Fischer, Albrecht G. Schmidt, Edwin Bölke, Markus Uhrberg, Verena Keitel, Torsten Feldt, Björn‐Erik Ole Jensen, Dieter Häussinger, Ortwin Adams, E. Marion Schneider et al. · 2021 · European journal of medical research
14. Presence and clinical impact of human herpesvirus‐6 infection in patients with moderate to critical coronavirus disease‐19
    Kátia Lino, Lilian Santos Alves, Jéssica Vasques Raposo, Thalia Medeiros, Cintia Fernandes Souza, Andréa Alice Silva, Vanessa Salete de Paula, Jorge Reis Almeida · 2021 · Journal of Medical Virology
15. Exosomes and COVID-19: challenges and opportunities
    Ghader Babaei, Nasrin Zare, Ainaz Mihanfar, Mohammad Hassan Khadem Ansari · 2022 · Comparative Clinical Pathology
16. Post-COVID-19 HSV encephalitis: a review
    S Gupta, Ajitava Dutta, Uddalak Chakraborty, Reginald Kumar, D Das, Biman Kanti Ray · 2022 · QJM
17. Biomarker based biosensors: An opportunity for diagnosis of COVID‐19
    Reza Khaksarinejad, Zohreh Arabpour, Leila Rezakhani, Farzad Parvizpour, Yousef Rasmi · 2022 · Reviews in Medical Virology
18. The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy
    Yiran Wang, Mandi Wu, Yichen Li, Ho Him Yuen, Ming‐Liang He · 2022 · Journal of Biomedical Science
19. The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity
    Sterre L. Siekman, Tamás Pongrácz, Wenjun Wang, Jan Nouta, Peter G. Kremsner, Pedro Vieira Da Silva-Neto, Meral Esen, Andrea Kreidenweiss, Jana Held, Átila Alexandre Trapé et al. · 2022 · Frontiers in Immunology
20. Natural killer cells for antiviral therapy
    Davey Mitchell Smith, Jolie R. Schafer, Brian P. Tullius, Laura Witkam, Silke Paust · 2023 · Science Translational Medicine
21. The Role of the Nuclear Factor-Kappa B (NF-κB) Pathway in SARS-CoV-2 Infection
    Periyanaina Kesika, Subramanian Thangaleela, Natarajan Sisubalan, Arumugam Radha, Bhagavathi Sundaram Sivamaruthi, Chaiyavat Chaiyasut · 2024 · Pathogens
22. Immunosenescence: A new direction in anti-aging research
    Hanzhou Li, Shan Lin, Yuming Wang, Yuexuan Shi, Xixing Fang, Jida Wang, Huantian Cui, Yuhong Bian, Xin Qi · 2024 · International Immunopharmacology
23. Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
    Yetian Dong, Tong Dai, Jun Liu, Long Zhang, Fangfang Zhou · 2020 · Advanced Science
24. Regulation of Human Innate Lymphoid Cells in the Context of Mucosal Inflammation
    Anja Schulz-Kuhnt, Stefan J. Wirtz, Markus Friedrich Neurath, Imke Atreya · 2020 · Frontiers in Immunology
25. Drug similarity and structure-based screening of medicinal compounds to target macrodomain-I from SARS-CoV-2 to rescue the host immune system: a molecular dynamics study
    Zainib Babar, Mazhar Khan, Mubeen Zahra, Munazza Anwar, Kashif Noor, Huma Farooque Hashmi, Muhammad Suleman, Muhammad Waseem, Abdullah Shah, Shahid Ali et al. · 2020 · Journal of Biomolecular Structure and Dynamics
26. Immune response to COVID-19 infection: a double-edged sword
    Norma Md Saad, Salim Moussa · 2021 · Immunological Medicine
27. Advances in immunotherapy for COVID-19: A comprehensive review
    Masoomeh Masoomikarimi, Behzad Garmabi, Javad Alizadeh, Erfan Kazemi, Amirhossein Azari Jafari, Seyyedmohammadsadeq Mirmoeeni, Motahareh Dargahi, Niloofar Taheri, Reza Jafari · 2021 · International Immunopharmacology
28. Risk Factors for COVID-19 in Patients with Hypertension
    Xinxin Wang, Haihua Zhang, Huan Du, Ruina Ma, Yandong Nan, Tao Zhang · 2021 · Canadian Journal of Infectious Diseases and Medical Microbiology
29. Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication
    Wen Juan Tu, Robert McCuaig, Michelle Melino, Daniel J. Rawle, Thuy T. Le, Kexin Yan, Andreas Suhrbier, Rebecca L. Johnston, Lambros T. Koufariotis, Nicola Waddell et al. · 2021 · Cell Discovery
30. Computational screening for potential drug candidates against the SARS-CoV-2 main protease
    Bruno Silva Andrade, Preetam Ghosh, Debmalya Barh, Sandeep Tiwari, Raner José Santana Silva, Wagner Rodrigues de Assis Soares, Tarcísio Silva Melo, Andria Santos Freitas, Patrícia González-Grande, Lucas Sousa Palmeira et al. · 2020 · F1000Research
31. A Comprehensive Updated Review on SARS‐CoV‐2 and COVID‐19
    Yunzhao R. Ren, Amit Golding, Alfred F. Sorbello, Ping Ji, Jianmeng Chen, Bhawana Saluja, Kimberly A. Witzmann, Vikram Arya, Kellie S. Reynolds, Suyoung Choi et al. · 2020 · The Journal of Clinical Pharmacology
32. Parallels in the Pathogenesis of SARS-CoV-2 and M. Tuberculosis : a synergistic or Antagonistic Alliance?
    Kesego Tapela, Charles Ochieng’ Olwal, Osbourne Quaye · 2020 · Future Microbiology
33. Papel del sistema inmune en la infección por el SARS-CoV-2: inmunopatología de la COVID-19
    J. Monserrat Sanz, Ana Maria Gomez-Lahoz, R. Oliva Martín · 2021 · Medicine - Programa de Formación Médica Continuada Acreditado
34. Impact of age and gender on lymphocyte subset counts in patients with COVID ‐19
    Phillip Löhr, Stefan Schiele, Tim Tobias Arndt, Stefanie Grützner, Rainer Claus, Christoph Römmele, Gernot Müller, Christoph Schmid, Kevin M. Dennehy, Andreas Rank · 2021 · Cytometry Part A
35. Phenotypes and Functions of SARS-CoV-2-Reactive T Cells
    Min Kyung Jung, Eui‐Cheol Shin · 2021 · Molecules and Cells
36. Deep learning identifies antigenic determinants of severe SARS-CoV-2 infection within T-cell repertoires
    John-William Sidhom, Alexander Spyridon Baras · 2021 · Scientific Reports
37. Restoring NK cells functionality via cytokine activation enhances cetuximab-mediated NK-cell ADCC: A promising therapeutic tool for HCC patients
    Shahenda Mahgoub, Hadeer Abosalem, Mohamed Mahrous Emara, Nahla S. Kotb, A. Maged, Sameh H. A. Soror · 2021 · Molecular Immunology
38. Biomarkers of severe COVID-19 pneumonia on admission using data-mining powered by common laboratory blood tests-datasets
    Mary Pulgar-Sánchez, Kevin Chamorro, Martha M Fors, Francisco X. Mora, Hégira Ramírez, Esteban Fernández-Moreira, Santiago Ballaz · 2021 · Computers in Biology and Medicine
39. Comprehensive Laboratory Data Analysis to Predict the Clinical Severity of Coronavirus Disease 2019 in 1,952 Patients in Daegu, Korea
    Eun‐Hyung Yoo, Soon Hee Chang, Do Young Song, Chae Hoon Lee, Gyu Young Cheong, Sunggyun Park, Jae Hee Lee, Sooin Lee, Sang Gyu Kwak, Chang‐Ho Jeon et al. · 2021 · Annals of Laboratory Medicine
40. Current scenario of COVID-19 vaccinations and immune response along with antibody titer in vaccinated inhabitants of different countries
    Asim Hussain, Hamza Rafeeq, Hafiza Memoona Asif, Sumaira Shabbir, Muhammad Bilal, Sikandar Imamsab Mulla, Marcelo Franco, Hafiz M.N. Iqbal · 2021 · International Immunopharmacology
41. Increased Blood Monocytic Myeloid Derived Suppressor Cells but Low Regulatory T Lymphocytes in Patients with Mild COVID-19
    Carlos Jiménez‐Cortegana, Julia Liró, Natalia Palazón Carrión, Elena Salamanca, Jesús Sojo-Dorado, Luis de la Cruz‐Merino, Álvaro Pascual, Jesús Rodríguez‐Baño, Víctor Sánchez‐Margalet · 2021 · Viral Immunology
42. SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies
    Ali Salimi Jeda, Sina Abbassi, Atieh Mousavizadeh, Maryam Esghaie, Farah Bokharaei‐Salim, Farhad Jeddi, Maryam Shafaati, Asghar Abdoli · 2021 · International Immunopharmacology
43. COVID‐19 in pregnant women and children: Insights on clinical manifestations, complexities, and pathogenesis
    Arun Meyyazhagan, Karthika Pushparaj, Balamuralikrishnan Balasubramanian, Haripriya Kuchi Bhotla, Manikantan Pappuswamy, Vijaya Anand Arumugam, Murugesh Easwaran, Lalitha Pottail, Mani Poonkothai, Valentina I. Tsibizova et al. · 2021 · International Journal of Gynecology & Obstetrics
44. Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines
    Yexin Yang, Akiko Iwasaki · 2021 · Current HIV/AIDS Reports
45. Vitamin D can reduce severity in COVID-19 through regulation of PD-L1
    Hatice Aygün · 2022 · Naunyn-Schmiedeberg s Archives of Pharmacology
46. Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients
    Lena Peter, Désirée J. Wendering, Stephan Schlickeiser, Henrike Hoffmann, Rebecca Noster, Dimitrios L. Wagner, Ghazaleh Zarrinrad, Sandra Münch, Samira Picht, Sarah Schulenberg et al. · 2022 · Molecular Therapy — Methods & Clinical Development
47. Acute kidney injury associated to COVID-19 leads to a strong unbalance of circulant immune mediators
    Thalia Medeiros, Gabriel Macedo Costa Guimarães, Fabiana Rabe Carvalho, Lilian Santos Alves, Renan da Silva Faustino, Ana Carolina Campi‐Azevedo, Vanessa Peruhype-Magalhães, Andréa Teixeira‐Carvalho, Matheus de Souza Gomes, Laurence Rodrigues do Amaral et al. · 2022 · Cytokine
48. Dissecting CD8+ T cell pathology of severe SARS-CoV-2 infection by single-cell immunoprofiling
    Felix Schreibing, Monica Toft Hannani, Hyojin Kim, James Shiniti Nagai, Fabio Ticconi, Eleanor Fewings, Tore Bleckwehl, Matthias Begemann, Natalia Torow, Christoph Kuppe et al. · 2022 · Frontiers in Immunology
49. Omega-3 Polyunsaturated Fatty Acids (n-3 PUFAs) for Immunomodulation in COVID-19 Related Acute Respiratory Distress Syndrome (ARDS)
    Francesca Velotti, Lara Costantini, Nicolò Merendino · 2022 · Journal of Clinical Medicine
50. COVID-19 and Frailty
    Tiziana Ciarambino, Pietro Crispino, Giovanni Minervini, Mauro Giordano · 2023 · Vaccines
51. The Potential of Probiotics as Ingestible Adjuvants and Immune Modulators for Antiviral Immunity and Management of SARS-CoV-2 Infection and COVID-19
    Sophie Tomkinson, Cloe Triscott, Emily Schenk, Andrew Foey · 2023 · Pathogens
52. NK-like CD8 T cell: one potential evolutionary continuum between adaptive memory and innate immunity
    Qiulei Wang, Shaodan Chen, Zhenhong Guo, Sheng Xia, Minghui Zhang · 2024 · Clinical & Experimental Immunology
53. TLR2/4 are novel activating receptors for SARS-CoV-2 spike protein on NK cells
    Nadine Landolina, Biancamaria Ricci, Irene Veneziani, Claudia Alicata, Francesca Romana Mariotti, Andrea Pelosi, Linda Quatrini, Eva Piano Mortari, Rita Carsetti, Paola Vacca et al. · 2024 · Frontiers in Immunology
54. Clinical predictors of COVID‐19 disease progression and death: Analysis of 214 hospitalised patients from Wuhan, China
    Jie Liu, Zilong Liu, Weipeng Jiang, Jian Wang, Mengchan Zhu, Juan Song, Xiaoyue Wang, Ying Su, Guiling Xiang, Maosong Ye et al. · 2020 · The Clinical Respiratory Journal
55. SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals
    Min‐Seok Rha, A Reum Kim, Eui‐Cheol Shin · 2021 · Immune Network
56. Is the epithelial barrier hypothesis the key to understanding the higher incidence and excess mortality during COVID‐19 pandemic? The case of Northern Italy
    Silvana Fiorito, Marzia Soligo, Yadong Gao, İsmail Öğülür, Cezmi A. Akdiş, Sergio Bonini · 2022 · Allergy
57. Can wearing face masks in public affect transmission route and viral load in COVID-19?
    Zuzana Ozaniak Strizova, Jiřina Bartůňková, Daniel Smrž · 2020 · Central European Journal of Public Health
58. Investigating Virological, Immunological, and Pathological Avenues to Identify Potential Targets for Developing COVID-19 Treatment and Prevention Strategies
    Zafar Mahmood, Hani Alrefai, ‏Helal F. Hetta, Hidaya Abdul Kader, Nayla Munawar, Sheikh Abdul Rahman, Shereen Elshaer, Gaber El‐Saber Batiha, Khalid Muhammad · 2020 · Vaccines
59. COVID-19 pathology: experience of 2000 autopsies
    Oleg V. Zayratyants, Maria V. Samsonova, Cherniaev Al, Mishnev Od, Л.М. Михалева, Крупнов Николай Михайлович, Dmitry Valerievich Kalinin · 2020 · Russian Journal of Forensic Medicine
60. COVID-19: Imbalanced Immune Responses and Potential Immunotherapies
    Bing Xie, Jiancheng Zhang, Yuwen Li, Shiying Yuan, You Shang · 2021 · Frontiers in Immunology
61. OMIP 078: A 31‐parameter panel for comprehensive immunophenotyping of multiple immune cells in human peripheral blood mononuclear cells
    Takuto Nogimori, Yuko Sugawara, Masaya Higashiguchi, Hirotomo Murakami, Hirofumi Akita, Shokichi Takahama, Satoshi Tanaka, Takuya Yamamoto · 2021 · Cytometry Part A
62. Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19?
    Christian Albert Devaux, Cléa Melenotte, Marie‐Dominique Piercecchi‐Marti, Clémence Delteil, Didier Raoult · 2021 · Frontiers in Medicine
63. Uncertainty around the Long-Term Implications of COVID-19
    Marc Desforges, Deepti Gurdasani, Adam Hamdy, Anthony Joseph Leonardi · 2021 · Pathogens
64. Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions
    Michael J. Peluso, Joanna L. Donatelli, Timothy J. Henrich · 2021 · Translational research
65. Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents
    Hing Wai Tsang, Gilbert T. Chua, Kelvin Kai‐Wang To, Joshua Sung Chih Wong, Wenwei Tu, Janette Kwok, Wilfred Hing Sang Wong, Xiwei Wang, Yanmei Zhang, Jaime S. Rosa Duque et al. · 2021 · Frontiers in Immunology
66. Activated CD8+CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients
    Anna Bobčáková, Martina Barnova, Róbert Vyšehradský, Jela Petriskova, Ivan Kocan, Zuzana Diamant, Miloš Jeseňák · 2022 · Frontiers in Immunology
67. Risk factors of the severe course and fatal outcome in COVID-19
    Sergey G. Sсherbak, Тatyana A. Kamilova, Александр Сергеевич Голота, Dmitry A. Vologzhanin · 2022 · Physical and rehabilitation medicine medical rehabilitation
68. The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update
    Saade Abdalkareem Jasim, Roaa Salih Mahdi, Dmitry Olegovich Bokov, Mazin A. A. Najm, Guzal N. Sobirova, Zarnigor Orifovna Bafoeva, Ahmed Taifi, Ola Kamal A. Alkadir, Yasser Fakri Mustafa, Rasoul Mirzaei et al. · 2022 · Journal of Medical Virology
69. Lessons from SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections: What We Know So Far
    Radi Alsafi · 2022 · Canadian Journal of Infectious Diseases and Medical Microbiology
70. Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences
    Durjoy Lahiri, Ritwick Mondal, Shramana Deb, Deebya Bandyopadhyay, Gourav Shome, Sukanya Sarkar, Subhas Chandra Biswas · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
71. Common laboratory tests as indicators of COVID-19 severity on admission at high altitude: a single-center retrospective study in Quito (ECUADOR)
    Santiago Ballaz, Mary Pulgar-Sánchez, Kevin Chamorro, Esteban Fernández-Moreira, Hégira Ramírez, Francisco X. Mora, Martha M Fors · 2021 · Clinical Chemistry and Laboratory Medicine (CCLM)
72. Demystifying Excess Immune Response in COVID-19 to Reposition an Orphan Drug for Down-Regulation of NF-κB: A Systematic Review
    Apparao Peddapalli, Manish Gehani, Arunasree Marasanapalli Kalle, Siva R. Peddapalli, Angela E. Peter, Shashwat Sharad · 2021 · Viruses
73. Hemophagocytic histiocytosis in severe SARS‐CoV‐2 infection: A bone marrow study
    Himanshu R. Dandu, Geeta Yadav, Hardeep Singh Malhotra, Saurabh Pandey, Ruovinuo Sachu, Kinjalk Dubey · 2021 · International Journal of Laboratory Hematology
74. The pigtail macaque (Macaca nemestrina) model of COVID-19 reproduces diverse clinical outcomes and reveals new and complex signatures of disease
    Alexandra Melton, Lara A. Doyle‐Meyers, Robert V. Blair, Cecily C. Midkiff, Hunter J. Melton, Kasi Russell‐Lodrigue, Pyone P. Aye, Faith R. Schiro, Marissa D. Fahlberg, Dawn M. Szeltner et al. · 2021 · PLoS Pathogens
75. Innate immunity to SARS-CoV-2 infection: a review
    Marcos Jessé Abrahão Silva, Yan Corrêa Rodrigues, Karla Valéria Batista Lima, Luana Nepomuceno Gondim Costa Lima · 2022 · Epidemiology and Infection
76. Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.
    Samuel F. Yanuck, Joseph E. Pizzorno, Helen Messier, Kara N. Fitzgerald · 2020 · PubMed Central
77. Antibody-Based Immunotherapeutic Strategies for COVID-19
    Jamal Hussen, Mahmoud K Kandeel, Maged Gomaa Hemida, Abdullah I. A. Al-Mubarak · 2020 · Pathogens
78. Potential Role of the Galectin-9/TIM-3 Axis in the Disparate Progression of SARS-CoV-2 in a Married Couple: A Case Report
    Alejandro Martín‐Quirós, Charbel Maroun‐Eid, José Avendaño Ortiz, Roberto Lozano‐Rodríguez, Jaime Valentín Quiroga, Verónica Terrón, Karla Marina Montalbán-Hernández, Miguel Ángel García-Garrido, Elena Muñoz del Val, Álvaro del Balzo‐Castillo et al. · 2021 · Biomedicine Hub
79. COVID-19: Mechanistic Model of the African Paradox Supports the Central Role of the NF-κB Pathway
    Ralf Kircheis, Manfred Schuster, Oliver Planz · 2021 · Viruses
80. Integrated analysis of circulating immune cellular and soluble mediators reveals specific COVID19 signatures at hospital admission with utility for prediction of clinical outcomes
    Iratxe Uranga-Murillo, Elena Morte-Romea, Sandra Hidalgo, Cecilia Pesini, Sandra García‐Mulero, José Luis Sierra-Monzón, Llipsy Santiago, Maykel A. Arias, Diego de Miguel, María del Mar Encabo-Berzosa et al. · 2021 · Theranostics
81. Dysfunctional State of T Cells or Exhaustion During Chronic Viral Infections and COVID-19: A Review
    K.P. Mishra, Mrinalini Singh, Deepika Saraswat, Lilly Ganju, Rajeev Kumar Varshney · 2022 · Viral Immunology
82. Allelic imbalance of HLA-B expression in human lung cells infected with coronavirus and other respiratory viruses
    Yuanxu Zhang, Yisheng Sun, Hanping Zhu, Hai Hong, Jianmin Jiang, Pingping Yao, Hua‐Xin Liao, Yanfeng Zhang · 2022 · European Journal of Human Genetics
83. Natural killer cell exhaustion in SARS-CoV-2 infection
    Janet Gallardo‐Zapata, Carmen Maldonado‐Bernal · 2022 · Innate Immunity
84. Dysregulation of immunity in COVID-19 and SLE
    Seyyed Sina Hejazian, Seyyedeh Mina Hejazian, Farahnoosh Farnood, Sima Abedi Azar · 2022 · Inflammopharmacology
85. Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function
    Sanaz Abbaspour‐Aghdam, Ali Hazrati, Samaneh Abdolmohammadi‐Vahid, Safa Tahmasebi, Jafar Hessam Mohseni, Hamed Valizadeh, Mehdi Nadiri, Haleh Mikaeili, Armin Sadeghi, Mehdi Yousefi et al. · 2022 · European Journal of Pharmacology
86. Non-classical HLA class I molecules and their potential role in viral infections
    Silvia Beltrami, Sabrina Rizzo, Giovanni Strazzabosco, Valentina Gentili, Andrea Alogna, Marco Narducci, Daria Bortolotti, Giovanna Schiuma, Roberta Rizzo · 2023 · Human Immunology
87. Emerging roles of SARS-CoV-2 Spike-ACE2 in immune evasion and pathogenesis
    Cosima T. Baldari, Anna Onnis, Emanuele Andreano, Giuseppe Del Giudice, Rino Rappuoli · 2023 · Trends in Immunology
88. COVID-19: from immune response to clinical intervention
    Zheng-yang Guo, Yanqing Tang, Zi-bo Zhang, Juan Liu, Yuxin Zhuang, Ting Li · 2024 · Precision Clinical Medicine
89. Coronaviral Infection (COVID-19) in Children (Situation on April 2020)
    Leyla Seymurovna Namazova-Baranova · 2020 · Педиатрическая фармакология
90. Natural killer cell responses to emerging viruses of zoonotic origin
    Carlos Díaz-Salazar, Joseph Chai-Yuen Sun · 2020 · Current Opinion in Virology
91. Isolation of SARS-CoV-2 strains carrying a nucleotide mutation, leading to a stop codon in the ORF 6 protein
    Serena Delbue, Sarah D’Alessandro, Lucia Signorini, Maria Dolci, Elena Pariani, Michele Bianchi, S. Fattori, Annalisa Modenese, Cristina Galli, Ivano Eberini et al. · 2021 · Emerging Microbes & Infections
92. Endothelial cell, myeloid, and adaptive immune responses in SARS‐CoV‐2 infection
    Nicolas Degauque, Alain Haziot, Sophie Brouard, Nuala Mooney · 2021 · The FASEB Journal
93. A Chinese host genetic study discovered IFNs and causality of laboratory traits on COVID-19 severity
    Huanhuan Zhu, Fang Zheng, Linxuan Li, Yan Jin, Yuxue Luo, Zhen Li, Jingyu Zeng, Ling Fung Paul Tang, Zilong Li, Ningyu Xia et al. · 2021 · iScience
94. SARS-CoV-2 Infection: A Possible Risk Factor for Incidence and Recurrence of Cancers
    Abdollah Jafarzadeh, Rohit Gosain, Seyed Mohammad Javad Mortazavi, Maryam Nemati, Sara Jafarzadeh, Abbas Ali Ghaderi · 2022 · International Journal of Hematology-Oncology and Stem Cell Research
95. COVID-19 and central nervous system interplay: A big picture beyond clinical manifestation
    Sutapa Som Chaudhury, Koel Sinha, Rabindranath Majumder, Atanu Biswas, Chitrangada Das Mukhopadhyay · 2021 · Journal of Biosciences
96. A systematic review and meta‐analysis of herpes zoster occurrence/recurrence after COVID‐19 infection and vaccination
    Fengge Wang, Yidan Gao, Abram Luther Wagner, Yihan Lu · 2024 · Journal of Medical Virology
97. The impact of COVID-19 on accelerating of immunosenescence and brain aging
    Ludmila Müller, Svetlana Di Benedetto · 2024 · Frontiers in Cellular Neuroscience
98. Molecular epidemiology of SARS CoV-2: a review of current data on genetic variability of the virus
    Parczewski, Miłosz, Ciechanowicz, Andrzej · 2020 · Polish Archives of Internal Medicine
99. Immunological features of coronavirus disease 2019 in patients with cancer
    Marion Thibaudin, Jean-David Fumet, Marjorie Bon, Léa Hampe, Emeric Limagne, François Ghiringhelli · 2020 · European Journal of Cancer
100. Clinical features and risk factors for severe inpatients with COVID-19: A retrospective study in China
     Juan Wang, Shuzhen Guo, Yili Zhang, Kuo Gao, Jiacheng Zuo, Nannan Tan, Kangjia Du, Yan Ma, Yong Hou, Quntang Li et al. · 2020 · PLoS ONE